Natco Pharma launches Albupax for breast cancer treatment: related news

Natco Pharma launches Albupax for breast cancer treatment

Natco Pharma, the Hyderabad-based pharma company has launched Albupax, a nanotechnology drug for treatment of breast cancer.

Natco launches nanotech drug for breast cancer

Hyderabad, Sept 19 Natco Pharma Ltd has launched its first nanotechnology drug, Albupax, for breast cancer treatment.

Pharma struggles to adapt as patents expire

pharma news, pharma newsletters, pharmaceutical companies, drug industry, dtc, fda, drug approvals, drug trials, biotech, pharma mergers, pharma acquisitions, pharma conferences, pharma patents, drug news, pharma executive, pharma business, pharma marketing

Natco Pharma Launches Nanotechnology Drug for Treatment of Breast Cancer

Add our nanotechnology news to del.icio.us Add our nanotechnology news to digg Add our nanotechnology news to NewsVine Add our nanotechnology news to Furl Add our nanotechnology news to YahooMyWeb Add our nanotechnology news to Reddit - Add our nanotechnology news to StumbleUpon - Add our nanotechnology news to Facebook -

Natco Makes Nanotechnology Debut With Launch of Breast Cancer Drug Albupax

(Nanowerk News) Natco Pharma, an Indian pharmaceutical company, has launched Albupax, its first nanotechnology drug.

Natco launches nanotechnology cancer drug in India

Natco Pharma has introduced its first nanotechnology drug, 'Albupax' in the domestic market. Currently, Albupax is available in some parts of country but soon it will have pan India availability.

A Robot To Destroy Breast Cancer Cells

Roland Piquepaille writes "Researchers at the University of Maryland are developing a robot able to detect and destroy breast cancer cells in a single session. After a tumor is located on an MRI, the robot will perform a biopsy of the breast while the patient is inside the scanner. 'If the biopsy displays cancerous cells, the robot will then insert a probe into the breast until it reaches the tumor. The probe will then burn the cancer cells until they are destroyed.' This looks great, but the researchers have only built a prototype. After they refine this robot, they'll need to go through clinical trials and obtain FDA approval. So this is not a robot that will appear on the medical market before several years."

NeoBiocon and Abraxis BioScience Launch Abraxane in The UAE for Treatment of Breast Cancer

NeoBiocon, a recently established biotechnology company and Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in the UAE for the treatment of breast cancer after failure of combination therapy for metastatic disease or relapse within six months of adjuvant chemotherapy.

HEALTH: Scientists find genes that increase lung cancer risk

An international research team has identified two genetic variations that appear to increase a person’s risk of developing lung cancer by up to 60 percent, they reported on Sunday. In April the same researchers identified another gene that raised lung cancer risk and they said their latest finding was relevant for both smokers and non-smokers. “We are looking at differences in the DNA that makes you more or less likely to develop lung cancer,” said Paul Brennan, a cancer epidemiologist at the World Health Organisation’s International Agency for Research on Cancer. “The idea is if you can identify genes then that might indicate why people develop lung cancer.”

Breakthrough Breast Cancer in online retail push

LONDON - Breakthrough Breast Cancer will launch its 2009 Fashion Targets Breast Cancer campaign with a new online retail platform supported by integrated marketing activity.

Comment From Breakthrough Breast Cancer On Possible New Genetic Testing Technique

"Only around 5% of all breast cancer cases are due to inherited faults in known breast cancer genes such as BRCA1 and BRCA2. Genetic testing is currently only offered to women with a strong family history of the disease and is not relevant for the majority of women.

Physical activity protects against breast cancer

Normal-weight women who exercise are approximately 30 per cent less likely to develop breast cancer than those who don't, scientists claim in a report published in the Breast Cancer Research journal today.

European patent office restores breast cancer gene patent

A pink ribbon is seen as a symbol of breast cancer awareness. The European Patent Office on Wednesday restored on appeal a controversial patent for a breast cancer gene that had been withdrawn from a US biotech firm, but granting it in a more restricted form than before.

Herceptin Brings New Age in Breast Cancer Care

Barbara Bradfield has lived to see dramatic changes in breast cancer. When she was diagnosed in 1989, Bradfield's tumor—which produced an overabundance of a protein called HER2—was considered especially deadly. Today, women with tumors like hers have some of the best survival rates in breast cancer.

Power3 Medical files two patent applications for breast cancer blood test

Add our medical news to StumbleUpon - Power3 Medical files two patent applications for breast cancer blood test Add our medical news to Facebook - Power3 Medical files two patent applications for breast cancer blood test

Technical Board of Appeal maintains two Myriad/breast cancer patents in limited form

An technical board of appeal of the European Patent Office has decided that the patent EP 699754, relating to a "Method for diagnosing a predisposition for breast and ovarian cancer", is to be maintained in an amended form. This decision sets aside the EPO's first instance decision of May 2004 to revoke the patent. This decision is the most recent one in a series of appeal proceedings relating to the human breast cancer gene BRCA1.

10/15/08 - Castle Biosciences Options Brain Cancer Test

Cancer diagnostics startup company Castle Biosciences (Houston, Tex.) has optioned a molecular diagnostic test for brain cancer. Developed by researchers at The University of Texas M. D. Anderson Cancer Center, the biomarker-based test is intended to prospectively assess a patient’s likelihood to respond to treatment for glioblastoma multiforme (GBM), the most common form of primary brain cancer. The test would be the company’s first product.

NEWS: MySpace Music launches with DRM-free downloads from Amazon

NEWS Shazam announces 1.5 million App Store downloads NEWS Super kid USB hub launches NEWS eBay launches iPhone app in Europe NEWS Microsoft provides three more Vista Ultimate "Extras" REVIEW Jabra BT4010 Bluetooth headset NEWS VIDEO OF THE DAY - Ableton beatbox NEWS Art Lebedev designs a mobile phone NEWS Kensington launches battery packs for iPhone and iPod NEWS Minox DSC digital spy camera launches NEWS LG launches Freeview+ home cinema system

Royal Philips Electronics, Celsion reach research agreement to Develop New Cancer Treatment - Quick Facts

(RTTNews) - Royal Philips Electronics (PHG: News ) and Celsion Corp. (CLSN: News ) revealed the signing of a joint research agreement focusing on a new cancer treatment that combines Philips' ultrasound technology with Celsion's drug delivery solution to target tumors with high concentrations of a cancer-fighting drug.

Philips and Celsion Announce Research Agreement to Develop New Cancer Treatment That Combines Ultrasound, Drug Delivery Technology

ANDOVER, Mass. and COLUMBIA, Md.--(BUSINESS WIRE)--Oct 16, 2008 - Royal Philips Electronics (NYSE: PHG; AEX: PHI) and Celsion Corporation (NASDAQ: CLSN) today announced the signing of a joint research agreement focusing on a new cancer treatment that combines Philips' ultrasound technology with Celsion's drug delivery solution to target tumors with high concentrations of a cancer-fighting drug.

Toshiba and Best Buy Go Pink

The Information Systems Group of Toshiba of Canada (Toshiba) and Best Buy are joining forces to support the Canadian Breast Cancer Foundation with the launch of Toshiba’s pink Portégé M800 laptop. Until the end of the year, $40 from the sale of each unit, available exclusively at Best Buy, will be contributed to the Canadian Breast Cancer Foundation to help support breast cancer research, and education and awareness programs.

Cancer Survivors Create Special Packaging Art for New Tea Flavors

In recognition of October’s National Breast Cancer Awareness Month, Celestial Seasonings tea has introduced two new antioxidant-rich green teas—Cranberry Pomegranate Green Tea and Tropical Grapefruit Green Tea—with box artwork created by breast cancer survivors Heidi Kummli and Dagmar Fehlau.

Stopping Cancer Cells Before They Start? Inhibitor Of Gene Regulator Discovered

North Carolina State University chemist has discovered a molecule that can potentially stop the production of cancer cells at the very beginning of the process by switching off the gene regulators responsible for turning healthy cells into cancer cells. The discovery could lead to the development of drugs that can treat some of the deadliest forms of cancer, including brain cancer.

Protein Compels Ovarian Cancer Cells to Cannibalize Themselves

Newswise - A protein known to inhibit the growth of ovarian cancer works in part by forcing cancer cells to eat themselves until they die, researchers at The University of Texas M. D. Anderson Cancer Center report in the Nov. 15 issue of Cancer Research.

Search took 0.34 seconds.